OTTAWA—Prices for prescription pharmaceuticals sold in Canada decreased, on average, by 0.4 percent during 2010, significantly smaller than the 1.8 percent inflation rate, and Canadian prices remain significantly below those in the United States, the Patented Medicine Prices Review Board said June 16.
The 2010 decrease represented a turnaround from the increases of 0.3 percent in 2009 and 0.1 percent in 2008, and contributed to a decrease in total sales of patented drug products in Canada by 3.4 percent to C$12.9 billion ($13.2 billion) in 2010, the federal agency said in its annual report to Parliament. That pushed the share ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.